Skip to main content

Closed

RLMD: Relmada Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-27.1%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio18.26×

Relmada Therapeutics, Inc.

RLMDNASDAQ·USD·Closed

Relmada Therapeutics, Inc.

RLMDNASDAQ·USD·Closed

$5.31

−0.75%

$5.31

−$0.04 (0.75%)

52W Range

64thpctl

Volume

1.01×avg

Mkt Cap

556.97MUSD

P/E

-4.8TTM

Div Yield

–ann

52W Range

64thpctl

Volume

1.01×avg

Market Cap

556.97MUSD

P/E Ratio

-4.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings